3.52

0.56% -0.02

Vigil Neuroscience Inc (VIGL)

Overview News Price History Financials Why VIGL Down? Discussions Forecast

Vigil Neuroscience Inc stock is currently priced at $3.52, with a 24-hour trading volume of 48,589. It has seen a -0.56% decreased in the last 24 hours and a +20.55% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $3.52 pivot point. If it approaches the $3.61 resistance level, significant changes may occur.

Previous Close:

$3.54

Open:

$3.56

24h Volume:

48,589

Market Cap:

$132.30M

Revenue:

Net Income/Loss:

$-78.92M

P/E Ratio:

-1.7255

EPS:

-2.04

Net Cash Flow:

$-72.87M

1W Performance:

+10.69%

1M Performance:

+20.55%

6M Performance:

-12.00%

1Y Performance:

-58.56%

1D Range:

$3.44

$3.63

52W Range:

$2.50

$11.11

Vigil Neuroscience Inc Stock (VIGL) Company Profile

Name

Vigil Neuroscience Inc

Sector

Healthcare (1209)

Industry

Biotechnology (699)

Phone

857 254 4445

Address

300 Technology Sq., Flr. 8, Cambridge

Employee

Twitter

Next Earnings Date

Latest SEC Filings

VIGL's Discussions on Twitter

Vigil Neuroscience Inc Stock (VIGL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-31-23	Initiated	Mizuho	Buy
Sep-16-22	Initiated	Wedbush	Outperform
Aug-29-22	Initiated	H.C. Wainwright	Buy
Feb-01-22	Initiated	Guggenheim	Buy
Feb-01-22	Initiated	Jefferies	Buy
Feb-01-22	Initiated	Morgan Stanley	Equal-Weight
Feb-01-22	Initiated	Stifel	Buy

View All

Vigil Neuroscience Inc Stock (VIGL) Latest News

Vigil Neuroscience Inc: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - The InvestChronicle

The InvestChronicle

Vigil Neuroscience, Inc. to Post Q2 2024 Earnings of ($0.51) Per Share, Wedbush Forecasts (NASDAQ:VIGL) - MarketBeat

MarketBeat

Vigil Neuroscience, Inc. (NASDAQ:VIGL) Sees Significant Growth in Short Interest - Defense World

Defense World

Q2 2024 Earnings Forecast for Vigil Neuroscience, Inc. (NASDAQ:VIGL) Issued By Wedbush - Defense World

Defense World

Vigil Neuroscience, Inc. (NASDAQ:VIGL) Short Interest Up 26.0% in April - MarketBeat

MarketBeat

Vigil Neuroscience (VIGL) Stock Forecast and Price Target 2024 - MarketBeat

MarketBeat

Vigil Neuroscience Inc Stock (VIGL) Financials Data

Vigil Neuroscience Inc (VIGL) Net Income 2024

VIGL net income (TTM) was -$78.92 million for the quarter ending September 30, 2023, a -25.60% decrease year-over-year.

Vigil Neuroscience Inc (VIGL) Cash Flow 2024

VIGL recorded a free cash flow (TTM) of -$72.87 million for the quarter ending September 30, 2023, a -10.27% decrease year-over-year.

Vigil Neuroscience Inc (VIGL) Earnings per Share 2024

VIGL earnings per share (TTM) was -$2.04 for the quarter ending September 30, 2023, a +5.96% growth year-over-year.

Vigil Neuroscience, Inc., a biotechnology company, discovers and develops novel therapeutics that take advantage of breakthroughs in science and human genetics of microglia. It harnesses the power of microglia for the treatment of neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. The company was incorporated in 2020 and is based in Cambridge, Massachusetts.